Bon Natural Life Ltd(BON)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-09-30.

Bon Natural Life Ltd (BON) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BON is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $29.9m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Bon Natural Life Ltd reports quarterly revenue of $18.7M, net income of $-2.0M, an operating margin of -8.7%. Top institutional holders of BON by reported 13-F value include XTX Topco Ltd, CITADEL ADVISORS, TWO SIGMA SECURITIES, based on the most recent SEC filings. BON trades on the Nasdaq exchange and files with the SEC under CIK 1816815. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bon Natural Life Ltd directly from SEC EDGAR.